{"id":"W2318057464","doi":"10.1158/1535-7163.targ-09-b160","title":"Abstract B160: ANG1005: New EPiC compound for the treatment of recurrent malignant glioma","year":2009,"lang":"en","type":"article","venue":"Molecular Cancer Therapeutics","topic":"Glioma Diagnosis and Treatment","field":"Medicine","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Intrinsik (Canada); Angiochem (Canada)","funders":"","keywords":"Glioma; Medicine; Tolerability; Neutropenia; Adverse effect; Taxane; Internal medicine; Cancer; Oncology; Gastroenterology; Pharmacology; Cancer research; Breast cancer; Toxicity","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.00005054709,0.0002325911,0.0003506644,0.00006346316,0.00007251967,0.00002086617,0.00009926534,0.00006891957,0.0000708849],"category_scores_gemma":[0.000002655703,0.0001390151,0.0003171931,0.0001599283,0.00004501752,0.00001788702,0.000005189746,0.00004628911,0.00000450774],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0002154875,"about_ca_system_score_gemma":0.0001476448,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0001669358,"about_ca_topic_score_gemma":0.00003394125,"domain_scores_codex":[0.9989412,0.00001554027,0.0002803475,0.0002447609,0.0002392972,0.0002787985],"domain_scores_gemma":[0.9991525,0.00007926004,0.0001287434,0.0004402545,0.00009146361,0.0001078049],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.0007701549,0.003046501,0.001437614,0.00004851391,0.001695364,0.0002197964,0.0007275218,0.0001601564,0.1958124,0.001350665,0.0006789631,0.7940523],"study_design_scores_gemma":[0.009779409,0.006009261,0.04887998,0.0002317665,0.002501237,0.00005932436,0.00009886258,0.0004576206,0.7296879,0.001480145,0.200496,0.0003184205],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.8982095,0.0871757,0.0006872295,0.0116133,0.000321379,0.001688043,0.00006319743,0.00003578092,0.0002059322],"genre_scores_gemma":[0.9924878,0.005450843,0.0006079513,0.001069888,0.0001409048,0.0001265528,0.00002626894,0.00002681109,0.00006294305],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.7937339,"threshold_uncertainty_score":0.566887,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.05376839915359866,"score_gpt":0.3395313373520377,"score_spread":0.2857629381984391,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}